Author: apopescu@pmlive.com

Building better relationships based on partnership and collaboration creates more effective outcomes

Business development director at Star, Ryan Wooller, discusses commercial outsourcing and how the company has adapted to provide the best solutions as pharma companies look to innovate and reduce costs

Biologic drugs are big. A heterogeneous mixture of more than 1,300 weighty amino acids, they are hundreds of times the 1- to 2 ml size of conventional small molecule injectables. That renders them hard to make – and even harder for patients to take.

Jeff Zucker of Worldwide Clinical Trials explains the key to improving study site performance

When we ignore carers, we miss out on one of our best shots at driving treatment success, says David Hunt, CEO of Havas Lynx